PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19920383-1	2009	S-1/CDDP combination chemotherapy is conducted in many institutions, but most patients are hospitalized at the time of CDDP administration.	cddp	119-123	proteasome 26S subunit, non-ATPase 1	Homo sapiens	0-3	
25731522-11	2014	The present case suggests that capecitabine/CDDP therapy may be an effective treatment for S-1 pretreated patients with advanced or metastatic gastric cancer.	cddp	44-48	proteasome 26S subunit, non-ATPase 1	Homo sapiens	91-94	
23997830-2	2013	Recently, two randomized phase III trials of S-1 combined with cisplatin (CDDP) or carboplatin (CBDCA) compared with the standard platinum doublet chemotherapy were reported.	cddp	74-78	proteasome 26S subunit, non-ATPase 1	Homo sapiens	45-48	
20037412-5	2009	Moreover, S-1 and CDDP combined chemotherapy (S-1: 120 mg/day, day 1-21/ 35 days, CDDP: 60 mg/m2, day 8/35 days) was performed as the second-line chemotherapy, nevertheless the diameter of liver metastasis enlarged to 26 mm.	cddp	18-22	proteasome 26S subunit, non-ATPase 1	Homo sapiens	46-49	
18553227-6	2008	Simultaneously, another Japanese phase III trial comparing S-1 with S-1 plus CDDP showed a survival benefit of S-1 plus CDDP.	cddp	120-124	proteasome 26S subunit, non-ATPase 1	Homo sapiens	59-62	
18553227-6	2008	Simultaneously, another Japanese phase III trial comparing S-1 with S-1 plus CDDP showed a survival benefit of S-1 plus CDDP.	cddp	120-124	proteasome 26S subunit, non-ATPase 1	Homo sapiens	68-71	
18553227-6	2008	Simultaneously, another Japanese phase III trial comparing S-1 with S-1 plus CDDP showed a survival benefit of S-1 plus CDDP.	cddp	120-124	proteasome 26S subunit, non-ATPase 1	Homo sapiens	68-71	
16897996-0	2006	[Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].	cddp	60-64	proteasome 26S subunit, non-ATPase 1	Homo sapiens	41-58	
18281772-8	2008	After CDDP 60 mg/body of day 8 was administered twice at S-1 80 mg/day, CEA became normal.	cddp	6-10	proteasome 26S subunit, non-ATPase 1	Homo sapiens	57-60	
17565259-6	2007	CDDP (60 mg/m2) administration was begun 8 days after the start of S-1.	cddp	0-4	proteasome 26S subunit, non-ATPase 1	Homo sapiens	67-70